Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution: A Randomized, Double-blind, Placebo-controlled Trial

NCT03433963 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT03433963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution: A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2018
Completion date
March 31, 2020
Enrollment
118 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, cardiac ischemia